Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Ethos Treatment Management, Ethos Treatment Planning

K-Number: K212294 · 2021-08-20

Decision Date2021-08-20
Product CodeIYE
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Ethos Treatment Management, Ethos Treatment Planning is a medical device manufactured by Varian Medical Systems, Inc.. It received FDA 510(k) clearance on 2021-08-20 under approval number K212294. The device is classified under product code IYE. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Ethos Treatment Management, Ethos Treatment Planning?

Ethos Treatment Management, Ethos Treatment Planning is a medical device that received FDA 510(k) clearance on 2021-08-20. It is manufactured by Varian Medical Systems, Inc.. The 510(k) number is K212294.

When was Ethos Treatment Management, Ethos Treatment Planning approved by the FDA?

Ethos Treatment Management, Ethos Treatment Planning received FDA 510(k) clearance on 2021-08-20, under approval number K212294.

What company makes Ethos Treatment Management, Ethos Treatment Planning?

Ethos Treatment Management, Ethos Treatment Planning is manufactured by Varian Medical Systems, Inc..

What is the FDA product code for Ethos Treatment Management, Ethos Treatment Planning?

The FDA product code for Ethos Treatment Management, Ethos Treatment Planning is IYE.

Related Clinical Trials

Related PubMed Literature

Other Devices by Varian Medical Systems, Inc.

View all 83 devices →

Related Devices (Code: IYE)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.